MAM
ROIV icon

Meeder Asset Management’s Roivant Sciences ROIV Stock Holding History

Meeder Asset Management’s Portfolio ROIV Stock Details ROIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.74K Sell
134
-153
-53% -$4.52K ﹤0.01% 847
2026
Q1 		$7.95K Buy
+287
New +$7.37K ﹤0.01% 745

Other funds holding ROIV

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
QF
QVT Financial New York $1.7B AUM 173.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

Meeder Asset Management's ROIV Position: Q2 2026 in Review

Meeder Asset Management reduced its Roivant Sciences (ROIV) stake by 53% in Q2 2026, selling an estimated $4.52K and leaving 134 shares worth $4.74K. The position accounts for ﹤0.01% of the portfolio, ranked #847.

Meeder Asset Management first reported a position in ROIV in Q1 2026 and has held it in 2 quarters since. The position peaked at $7.95K in Q1 2026. 498 funds tracked by Wall St. Rank hold ROIV as of Q2 2026.

  • Meeder Asset Management held 134 shares of Roivant Sciences worth $4.74K as of Q2 2026.
  • Meeder Asset Management sold 153 Roivant Sciences shares in Q2 2026, an estimated $4.52K.
  • Roivant Sciences made up ﹤0.01% of Meeder Asset Management's portfolio in Q2 2026, its #847 holding.
  • Meeder Asset Management first reported a position in Roivant Sciences in Q1 2026 and has held it in 2 quarters since.
  • Meeder Asset Management's Roivant Sciences position peaked at $7.95K in Q1 2026.
  • 498 funds tracked by Wall St. Rank held Roivant Sciences as of Q2 2026.

Based on Meeder Asset Management's 13F filing for Q2 2026, filed 7 Aug 2026.